The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing

Les Dethlefsen, Sue Huse, Mitchell L Sogin, David A Relman, Les Dethlefsen, Sue Huse, Mitchell L Sogin, David A Relman

Abstract

The human intestinal microbiota is essential to the health of the host and plays a role in nutrition, development, metabolism, pathogen resistance, and regulation of immune responses. Antibiotics may disrupt these coevolved interactions, leading to acute or chronic disease in some individuals. Our understanding of antibiotic-associated disturbance of the microbiota has been limited by the poor sensitivity, inadequate resolution, and significant cost of current research methods. The use of pyrosequencing technology to generate large numbers of 16S rDNA sequence tags circumvents these limitations and has been shown to reveal previously unexplored aspects of the "rare biosphere." We investigated the distal gut bacterial communities of three healthy humans before and after treatment with ciprofloxacin, obtaining more than 7,000 full-length rRNA sequences and over 900,000 pyrosequencing reads from two hypervariable regions of the rRNA gene. A companion paper in PLoS Genetics (see Huse et al., doi: 10.1371/journal.pgen.1000255) shows that the taxonomic information obtained with these methods is concordant. Pyrosequencing of the V6 and V3 variable regions identified 3,300-5,700 taxa that collectively accounted for over 99% of the variable region sequence tags that could be obtained from these samples. Ciprofloxacin treatment influenced the abundance of about a third of the bacterial taxa in the gut, decreasing the taxonomic richness, diversity, and evenness of the community. However, the magnitude of this effect varied among individuals, and some taxa showed interindividual variation in the response to ciprofloxacin. While differences of community composition between individuals were the largest source of variability between samples, we found that two unrelated individuals shared a surprising degree of community similarity. In all three individuals, the taxonomic composition of the community closely resembled its pretreatment state by 4 weeks after the end of treatment, but several taxa failed to recover within 6 months. These pervasive effects of ciprofloxacin on community composition contrast with the reports by participants of normal intestinal function and with prior assumptions of only modest effects of ciprofloxacin on the intestinal microbiota. These observations support the hypothesis of functional redundancy in the human gut microbiota. The rapid return to the pretreatment community composition is indicative of factors promoting community resilience, the nature of which deserves future investigation.

Conflict of interest statement

Competing interests. The authors have declared that no competing interests exist.

Figures

Figure 1. Genetic Distances between Tags and…
Figure 1. Genetic Distances between Tags and Reference Sequences
The genetic distances between each unique V6 tag (A) and V3 tag (B) and its best hit (or hits) in the appropriate reference database is shown on the vertical axis (see Methods for details); the abundance of the tag is shown on a logarithmic scale on the horizontal axis. Horizontal arrows indicate cumulative totals of tags from most to least abundant. Discrete horizontal rows of symbols near the x-axis correspond to an integer number of nucleotide changes relative to a reference sequence; vertical arrows indicate cumulative tag totals for up to 0, 1, or 2 changes. Abundant tags are likely to be identical to sequences in the reference databases; rare tags display a range of distances.
Figure 2. Rank Abundance Curves
Figure 2. Rank Abundance Curves
OTU abundance is shown on a logarithmic scale on the vertical axis; OTUs (defined as described in Methods) are listed in rank order along the horizontal axis. The dashed horizontal line at abundance 5 corresponds to an estimated probability of detection of 99%, based on the appearance of a rare OTU in a tag or sequence library according to the Poisson distribution. A comparison of V6, V3, and full-length libraries is shown in (A); the abundance per subject for V6 and V3 refOTUs are shown in (B and C). The maximum V3 refOTU abundance and number of V3 refOTUs are higher for individual A than other participants (C) because three additional samples were analyzed for this subject.
Figure 3. Rarefaction Curves
Figure 3. Rarefaction Curves
The vertical axis shows the number of OTUs that would be expected to be found after sampling the number of tags or sequences shown on the horizontal axis. Curvature toward the horizontal indicates the increased sequencing effort required to observe novel OTUs when only rare OTUs remain to be discovered. Text boxes indicate the final observed OTU richness (O), range of estimated OTU richness by the ACE, ICE, Chao 1 and Chao 2 nonparametric estimators (E) [–63], and Good's coverage (C) [64] for each method. The nonparametric estimators indicate that total OTU richness is much higher than currently observed, but are known to underestimate the true richness when the number of observations (i.e., tags or sequences) is small relative to the size of the community [60,63]. Good's coverage, the proportion of tags or sequences found in OTUs containing at least one other member, is an estimate of the probability that a tag or sequence drawn at random from the pool of amplicons will belong to an OTU that has already been detected.
Figure 4. Relative Abundance of Taxa across…
Figure 4. Relative Abundance of Taxa across Samples
The heatmaps show the relative abundance per sample of V3 refOTUs with total abundance of at least ten, after normalizing to an equal number of tags per sample (see Methods). Color intensity for all panels is directly proportional to the logarithm of normalized OTU abundance from 0 to 300; the 473 highest refOTU abundance values per sample, ranging from 300 to 19,964, are shown at maximum color intensity. Each column in the heatmaps represents one sample, arranged chronologically from left to right within individuals; blue bars above columns indicate Cp-associated samples. Each row represents a V3 refOTU, arranged alphabetically in a taxonomic hierarchy from phylum to genus, and by decreasing abundance within a genus. (A) All 1,450 V3 refOTUs with total normalized abundance of at least ten. The staggered bars on the left indicate phyla (Ac = Actinobacteria, Ba = Bacteroidetes, Fi = Firmicutes, Pr = Proteobacteria, Ve = Verrucomicrobia). Numbers on the right represent prominent genera or higher taxonomic ranks when refOTUs could not be classified to the genus level (see Methods for details): 1. Bifidobacteria, 2. Bacteroides, 3. Parabacteroides, 4. Alistipes, 5. Oscillospira, 6. Dialister, 7. Clostridium, 8. Dorea, 9. Faecalibacterium, 10. Subdoligranulum, 11. Clostridiaceae (family), 12. Eubacterium, 13. Anaerostipes, 14. Coprococcus and Lachnospira (2 thin bands at this position), 15. Roseburia, 16. Ruminococcus, 17. Lachnospiraceae (family), 18. Clostridiales (order), 19. Firmicutes (phylum), 20. Sutterella, 21. Akkermansia. (B–D) The normalized relative abundance in detail (same data as (A)) for V3 refOTUs in the three most abundant genera, Bacteroides, Faecalibacterium, and Roseburia.
Figure 5. Diversity Statistics
Figure 5. Diversity Statistics
(A) Observed taxon richness (number of V3 refOTUs) per sample; Cp-associated samples have significantly fewer OTUs than pre- and post-Cp samples for individuals A and B (p < 0.005) but not individual C (p = 0.129). (B) Shannon diversity index; Cp-associated samples are significantly less diverse than other samples for all individuals (p < 0.001). (C) Shannon equitability index; OTU abundance in Cp-associated samples is significantly less evenly distributed than OTU abundance in other samples for all individuals (p < 0.001 for A and B, p < 0.05 for C). Formulas for diversity and evenness are given in Methods; significance is assessed as the probability that the Cp-associated value is drawn from the lower tail of a normal distribution with mean and variance as calculated from the other samples.
Figure 6. PCA of Relative Taxon Abundance
Figure 6. PCA of Relative Taxon Abundance
Principal component analysis (PCA) of log2-transformed normalized abundance for 1,450 V3 refOTUs with normalized total abundance of at least ten (same data as in Figure 4A). Cp-associated samples are shown with open symbols, other samples with filled symbols. (A) PCA axis 1 (accounting for 35.3% of intersample variation) separates the samples of individual B from those of individuals A and C; PCA axis 2 (18.2% of intersample variation) separates Cp-associated samples from others. The separation of the Cp-associated samples from others is greatest for individual A, intermediate for B, and least for C, consistent with the heatmaps (Figure 4) and diversity statistics (Figure 5). (B) PCA axis 3 (9.7% of intersample variation) captures temporal variability in non-Cp samples of individual A, and to a lesser extent, individual C. Three samples collected from individual A in the week prior to Cp treatment cluster together at one extreme of the range of axis 3 values. (C) PCA axis 2 versus PCA axis 3. (D) Scree plot showing the proportion of variance explained by the first 5 PCA axes; the dashed line at 0.059 indicates the amount of variance expected for each axis with random, uncorrelated data.
Figure 7. Abundant Taxa in the genus…
Figure 7. Abundant Taxa in the genus Bacteroides
The relative abundance per subject of Bacteroides V3 refOTUs, expressed as the percentage of all V3 tags from that subject. The 19 most abundant Bacteroides refOTUs range from the first to the 91st most abundant taxa overall. Eighteen of these 19 Bacteroides refOTUs differ significantly in abundance between subjects (p < 0.05, FDR = 1.9%, NS marks the exception), but the abundance of the Bacteroides genus as a whole does not (p = 0.075, FDR 15%). Numbers in the legend indicate the rank order normalized abundance of refOTUs within Bacteroides, and correspond to the designation of the OTU according to the convention of this report (i.e., “1” represents V3_Bacteroides_refOTU_1.) The dominant tag in 15 of the 19 most abundant Bacteroides refOTUs has a perfect match to reference sequences from the cultivated species named in the legend.
Figure 8. Individualized Cp Responses
Figure 8. Individualized Cp Responses
Normalized abundance is shown on the vertical axis for selected V3 refOTUs (scales differ between panels); samples are ordered chronologically along the horizontal axis. Cp-associated samples are shown with open symbols. (A–H) Eight taxa among the 90 most abundant V3 refOTUs that show contrasting responses to Cp among individuals. Temporal variability is also evident at times not associated with Cp use.

References

    1. Dethlefsen L, McFall-Ngai M, Relman DA. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature. 2007;449:811–818.
    1. Ley RE, Peterson DA, Gordon JI. Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell. 2006;124:837–848.
    1. Guarner F. Enteric flora in health and disease. Digestion. 2006;73(Suppl: 1):5–12.
    1. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg. 2005;133:139–146.
    1. Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004;28:405–440.
    1. Reid G, Bruce AW. Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol. 2006;24:28–32.
    1. Li M, Wang B, Zhang M, Rantalainen M, Wang S, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci U S A. 2008;105:2117–2122.
    1. Hooper LV. Bacterial contributions to mammalian gut development. Trends Microbiol. 2004;12:129–134.
    1. Mazmanian SK, Liu CH, Tzianabos AO, Kasper DL. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell. 2005;122:107–118.
    1. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–241.
    1. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1:101–114.
    1. Beaugerie L, Petit JC. Microbial-gut interactions in health and disease. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol. 2004;18:337–352.
    1. Wilcox MH. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol. 2003;17:475–493.
    1. Marra F, Lynd L, Coombes M, Richardson K, Legal M, et al. Does antibiotic exposure during infancy lead to development of asthma?: a systematic review and metaanalysis. Chest. 2006;129:610–618.
    1. Noverr MC, Huffnagle GB. The 'microflora hypothesis' of allergic diseases. Clin Exp Allergy. 2005;35:1511–1520.
    1. Prioult G, Nagler-Anderson C. Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation. Immunol Rev. 2005;206:204–218.
    1. Nicholson JK, Holmes E, Wilson ID. Gut microorganisms, mammalian metabolism and personalized health care. Nat Rev Microbiol. 2005;3:431–438.
    1. O'Keefe SJ, Chung D, Mahmoud N, Sepulveda AR, Manafe M, et al. Why do African Americans get more colon cancer than Native Africans. J Nutr. 2007;137:175S–182S.
    1. McGarr SE, Ridlon JM, Hylemon PB. Diet, anaerobic bacterial metabolism, and colon cancer: a review of the literature. J Clin Gastroenterol. 2005;39:98–109.
    1. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, et al. Obesity alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070–11075.
    1. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A. 2004;101:15718–15723.
    1. Stewart CS, Duncan SH, Cave DR. Oxalobacter formigenes and its role in oxalate metabolism in the human gut. FEMS Microbiol Lett. 2004;230:1–7.
    1. Lode H, Von der Hoh N, Ziege S, Borner K, Nord CE. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora. Scand J Infect Dis. 2001;33:899–903.
    1. De La Cochetiere MF, Durand T, Lepage P, Bourreille A, Galmiche JP, et al. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol. 2005;43:5588–5592.
    1. Donskey CJ, Hujer AM, Das SM, Pultz NJ, Bonomo RA, et al. Use of denaturing gradient gel electrophoresis for analysis of the stool microbiota of hospitalized patients. J Microbiol Meth. 2003;54:249–256.
    1. Jernberg C, Lofmark S, Edlund C, Jansson JK. Long-term ecological impacts of antibiotic administration on the human intestinal microbiota. Isme J. 2007;1:56–66.
    1. Lofmark S, Jernberg C, Billstrom H, Andersson DI, Edlund C. Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine. Anaerobe. 2008;14:157–160.
    1. Sjolund M, Wreiber K, Andersson DI, Blaser MJ, Engstrand L. Long-term persistence of resistant Enterococcus species after antibiotics to eradicate Helicobacter pylori. Ann Intern Med. 2003;139:483–487.
    1. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915–1920.
    1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, et al. Diversity of the human intestinal microbial flora. Science. 2005;308:1635–1638.
    1. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, et al. Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol. 1999;65:4799–4807.
    1. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. Molecular ecological analysis of the gastrointestinal microbiota: a review. J Nutr. 2004;134:465–472.
    1. Mai V, Morris JG., Jr. Colonic bacterial flora: changing understandings in the molecular age. J Nutr. 2004;134:459–464.
    1. Bartosch S, Fite A, Macfarlane GT, McMurdo ME. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl Environ Microbiol. 2004;70:3575–3581.
    1. Bartosch S, Woodmansey EJ, Paterson JC, McMurdo ME, Macfarlane GT. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria. Clin Infect Dis. 2005;40:28–37.
    1. Vanhoutte T, Huys G, De Brandt E, Swings J. Temporal stability analysis of the microbiota in human feces by denaturing gradient gel elctrophoresis using universal and group-specific 16S rRNA gene primers. FEMS Microbiol Ecol. 2004;48:437–446.
    1. Jernberg C, Sullivan A, Edlund C, Jansson JK. Monitoring of antibiotic-induced alterations in the human intestinal microflora and detection of probiotic strains by use of terminal restriction fragment length polymorphism. Appl Environ Microbiol. 2005;71:501–506.
    1. Margulies M, Egholm M, Altman WE, Attiya S, Bader JS, et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature. 2005;437:376–380.
    1. Sogin ML, Morrison HG, Huber JA, Mark Welch D, Huse SM, et al. Microbial diversity in the deep sea and the underexplored “rare biosphere”. Proc Natl Acad Sci U S A. 2006;103:12115–12120.
    1. Liu Z, Lozupone C, Hamady M, Bushman FD, Knight R. Short pyrosequencing reads suffice for accurate microbial community analysis. Nucleic Acids Res. 2007;35:e120.
    1. Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73:5261–5267.
    1. Huber JA, Mark Welch DB, Morrison HG, Huse SM, Neal PR, et al. Microbial population structures in the deep marine biosphere. Science. 2007;318:97–100.
    1. Huse SM, Huber JA, Morrison HG, Sogin ML, Welch DM. Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol. 2007;8:R143.
    1. Roesch LF, Fulthorpe RR, Riva A, Casella G, Hadwin AK, et al. Pyrosequencing enumerates and contrasts soil microbial diversity. Isme J. 2007;1:283–290.
    1. McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, et al. The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 2008;4(2):e20. doi: .
    1. Hamady M, Walker JJ, Harris JK, Gold NJ, Knight R. Error-correcting barcoded primers for pyrosequencing hundreds of samples in multiplex. Nat Methods. 2008;5:235–237.
    1. Sundquist A, Bigdeli S, Jalili R, Druzin ML, Waller S, et al. Bacterial flora-typing with targeted, chip-based pyrosequencing. BMC Microbiol. 2007;7:108. doi: .
    1. Huse SM, Dethlefsen L, Huber JA, Welch DM, Relman DA, et al. Exploring microbial diversity and taxonomy using SSU rRNA hypervariable tag sequencing. PLoS Genet. 2008;4(11):e1000255. doi: .
    1. Thompson JR, Marcelino LA, Polz MF. Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'. Nucleic Acids Res. 2002;30:2083–2088.
    1. Ewing B, Green P. Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res. 1998;8:186–194.
    1. Ewing B, Hillier L, Wendl MC, Green P. Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res. 1998;8:175–185.
    1. Gordon D, Abajian C, Green P. Consed: a graphical tool for sequence finishing. Genome Res. 1998;8:195–202.
    1. DeSantis TZ, Jr., Hugenholtz P, Keller K, Brodie EL, Larsen N, et al. NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res. 2006;34:W394–399.
    1. DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006;72:5069–5072.
    1. Ludwig W, Strunk O, Westram R, Richter L, Meier H, et al. ARB: a software environment for sequence data. Nucleic Acids Res. 2004;32:1363–1371.
    1. Schloss PD, Handelsman J. Introducing DOTUR, a Computer Program for Defining Operational Taxonomic Units and Estimating Species Richness. Appl Environ Microbiol. 2005;71:1501–1506.
    1. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, et al. SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007;35:7188–7196.
    1. Colwell RK. EstimateS: Statistical estimation of species richness and shared species from samples. Version 7.5. 2005. Persistent URL < >. 7.5 ed.
    1. Leek JT, Monsen E, Dabney AR, Storey JD. EDGE: extraction and analysis of differential gene expression. Bioinformatics. 2006;22:507–508.
    1. Hughes JB, Hellmann JJ, Ricketts TH, Bohannan BJ. Counting the uncountable: statistical approaches to estimating microbial diversity. Appl Environ Microbiol. 2001;67:4399–4406.
    1. Chao A. Non-parametric estimation of the number of classes in a population. Scan J Stat. 1984;11:265–270.
    1. Chao A, Lee SM, Jeng SL. Estimating population size for capture-recapture data when capture probabilities vary by time and individual animal. Biometrics. 1992;48:201–216.
    1. Colwell RK, Coddington JA. Estimating terrestrial biodiversity through extrapolation. Philos Trans R Soc Lond B Biol Sci. 1994;345:101–118.
    1. Good IJ. On the population frequency of species and the estimation of population parameters. Biometrika. 1953;40:237–264.
    1. Hedlund BP, Gosink JJ, Staley JT. Verrucomicrobia div. nov., a new division of the bacteria containing three new species of Prosthecobacter. Antonie Van Leeuwenhoek. 1997;72:29–38.
    1. Derrien M, Vaughan EE, Plugge CM, de Vos WM. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int J Syst Evol Microbiol. 2004;54:1469–1476.
    1. Jost L. Entropy and diversity. Oikos. 2006;113:363–375.
    1. Jost L. Partitioning diversity into independent alpha and beta components. Ecology. 2007;88:2427–2439.
    1. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol. 1998;64:3336–3345.
    1. Matsuki T, Watanabe K, Fujimoto J, Takada T, Tanaka R. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol. 2004;70:7220–7228.
    1. Hayashi H, Sakamoto M, Benno Y. Fecal microbial diversity in a strict vegetarian as determined by molecular analysis and cultivation. Microbiol Immunol. 2002;46:819–831.
    1. De La Cochetiere MF, Durand T, Lalande V, Petit JC, Potel G, et al. Effect of antibiotic therapy on human fecal microbiota and the relation to the development of Clostridium difficile. Microb Ecol. 2008;56:395–402.
    1. Ozaki E, Kato H, Kita H, Karasawa T, Maegawa T, et al. Clostridium difficile colonization in healthy adults: transient colonization and correlation with enterococcal colonization. J Med Microbiol. 2004;53:167–172.
    1. Flint HJ, Duncan SH, Scott KP, Louis P. Interactions and competition within the microbial community of the human colon: links between diet and health. Environ Microbiol. 2007;9:1101–1111.
    1. Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, et al. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate-producing anaerobes from the human gut. Appl Environ Microbiol. 2006;72:3593–3599.
    1. Martin FP, Dumas ME, Wang Y, Legido-Quigley C, Yap IK, et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol Syst Biol. 2007;3:112.
    1. Ridlon JM, Kang DJ, Hylemon PB. Bile salt biotransformations by human intestinal bacteria. J Lipid Res. 2006;47:241–259.
    1. Pena JA, Li SY, Wilson PH, Thibodeau SA, Szary AJ, et al. Genotypic and phenotypic studies of murine intestinal lactobacilli: species differences in mice with and without colitis. Appl Environ Microbiol. 2004;70:558–568.
    1. Servin AL, Coconnier MH. Adhesion of probiotic strains to the intestinal mucosa and interaction with pathogens. Best Pract Res Clin Gastroenterol. 2003;17:741–754.
    1. Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. J Antimicrob Chemother. 2003;52:308–311.
    1. Bedford Russell AR, Murch SH. Could peripartum antibiotics have delayed health consequences for the infant. Bjog. 2006;113:758–765.
    1. Young VB, Schmidt TM. Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota. J Clin Microbiol. 2004;42:1203–1206.
    1. Duncan SH, Louis P, Flint HJ. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70:5810–5817.
    1. Duncan SH, Aminov RI, Scott KP, Louis P, Stanton TB, et al. Proposal of Roseburia faecis sp. nov., Roseburia hominis sp. nov. and Roseburia inulinivorans sp. nov., based on isolates from human faeces. Int J Syst Evol Microbiol. 2006;56:2437–2441.
    1. Louis P, Duncan SH, McCrae SI, Millar J, Jackson MS, et al. Restricted distribution of the butyrate kinase pathway among butyrate-producing bacteria from the human colon. J Bacteriol. 2004;186:2099–2106.
    1. Schumacher UK, Eiring P, Hacker FM. Incidence of Bilophila wadsworthia in appendiceal, peritoneal and fecal samples from children. Clin Microbiol Infect. 1997;3:134–136.
    1. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis 41 Suppl. 2005;2:S120–126.
    1. Forney LJ, Zhou X, Brown CJ. Molecular microbial ecology: land of the one-eyed king. Curr Opin Microbiol. 2004;7:210–220.
    1. von Wintzingerode F, Gobel UB, Stackebrandt E. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol Rev. 1997;21:213–229.
    1. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature. 2006;444:1022–1023.
    1. von Mering C, Hugenholtz P, Raes J, Tringe SG, Doerks T, et al. Quantitative phylogenetic assessment of microbial communities in diverse environments. Science. 2007;315:1126–1130.
    1. Ashelford KE, Chuzhanova NA, Fry JC, Jones AJ, Weightman AJ. New screening software shows that most recent large 16S rRNA gene clone libraries contain chimeras. Appl Environ Microbiol. 2006;72:5734–5741.

Source: PubMed

3
Subscribe